Stock Scorecard
Stock Summary for Baxter International Inc (BAX) - $20.23 as of 1/13/2026 9:09:20 AM EST
Total Score
8 out of 30
Safety Score
45 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for BAX
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for BAX
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for BAX
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for BAX
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for BAX (45 out of 100)
| Stock Price Rating (Max of 10) | 7 |
| Historical Stock Price Rating (Max of 10) | 8 |
| Stock Price Trend (Max of 10) | 1 |
| Book Value (Max of 10) | 5 |
| Book Value to Price (Max of 10) | 1 |
| Analyst Buy Ratings (Max of 5) | 3 |
| Analyst Strong Buy Ratings (Max of 5) | 3 |
| Dividend Yield Percentage (Max of 10) | 4 |
| Operating Margin (Max of 10) | 3 |
| Trading Volume (Max of 10) | 10 |
| Price to Earnings (Max of 10) | 0 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for BAX
Financial Details for BAX
Company Overview |
|
|---|---|
| Ticker | BAX |
| Company Name | Baxter International Inc |
| Country | USA |
| Description | Baxter International Inc. is a prominent American multinational healthcare company headquartered in Deerfield, Illinois, dedicated to advancing patient outcomes through innovative medical technologies. With a robust portfolio specializing in critical therapies for hemophilia, kidney disease, and immune disorders, Baxter effectively addresses both chronic and acute medical needs. The company’s unwavering commitment to quality and patient-centered solutions allows it to adeptly navigate the complex global healthcare landscape, ensuring a strategic position for sustained growth and long-term impact in the industry. |
| Sector Name | HEALTHCARE |
| Industry Name | MEDICAL INSTRUMENTS & SUPPLIES |
| Most Recent Quarter | 9/30/2025 |
| Next Earnings Date | N/A |
Stock Price History |
|
| Last Day Price | 20.23 |
| Price 4 Years Ago | 47.27 |
| Last Day Price Updated | 1/13/2026 9:09:20 AM EST |
| Last Day Volume | 11,530,211 |
| Average Daily Volume | 8,397,886 |
| 52-Week High | 37.25 |
| 52-Week Low | 17.39 |
| Last Price to 52 Week Low | 16.33% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 647.99 |
| Sector PE | 123.98 |
| 5-Year Average PE | 14.23 |
| Free Cash Flow Ratio | 6.02 |
| Industry Free Cash Flow Ratio | 32.74 |
| Sector Free Cash Flow Ratio | 29.04 |
| Current Ratio Most Recent Quarter | 1.84 |
| Total Cash Per Share | 3.36 |
| Book Value Per Share Most Recent Quarter | 14.09 |
| Price to Book Ratio | 1.50 |
| Industry Price to Book Ratio | 3.44 |
| Sector Price to Book Ratio | 24.69 |
| Price to Sales Ratio Twelve Trailing Months | 0.98 |
| Industry Price to Sales Ratio Twelve Trailing Months | 79.25 |
| Sector Price to Sales Ratio Twelve Trailing Months | 19.33 |
| Analyst Buy Ratings | 2 |
| Analyst Strong Buy Ratings | 1 |
Share Statistics |
|
| Total Shares Outstanding | 514,056,000 |
| Market Capitalization | 10,399,352,880 |
| Institutional Ownership | 103.71% |
Dividends |
|
| Ex-Dividend Date | 11/28/2025 |
| Previous Dividend Amount | 0.1700 |
| Current Dividend Amount | 0.0100 |
| Total Years Dividend Increasing | 0 |
| Trailing Annual Dividend Rate | 0.52 |
| Trailing Annual Dividend Yield | 2.46% |
| Forward Annual Dividend Rate | 0.04 |
| Forward Annual Dividend Yield | 0.19% |
| 5-Year Dividend Payments Count | 20 |
| 3-Year Average Dividend Yield | 3.16% |
| 5-Year Average Dividend Yield | 2.66% |
| 1-Year Dividend Growth Rate Percentage | -50.00% |
| 3-Year Dividend Growth Rate Percentage | -33.05% |
| 5-Year Dividend Growth Rate Percentage | -16.80% |
| All-Time Dividend Growth Rate Percentage | 3.03% |
| Dividend Payout Ratio | -74.29% |
Income Statement |
|
| Quarterly Earnings Growth YOY | 237.90% |
| Annual Earnings Growth | -124.44% |
| Reported EPS 12 Trailing Months | -0.70 |
| Reported EPS Past Year | 1.83 |
| Reported EPS Prior Year | 2.40 |
| Net Income Twelve Trailing Months | -341,000,000 |
| Net Income Past Year | -649,000,000 |
| Net Income Prior Year | 2,656,000,000 |
| Quarterly Revenue Growth YOY | 5.00% |
| 5-Year Revenue Growth | -1.31% |
| Operating Margin Twelve Trailing Months | 10.10% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 1,726,000,000 |
| Total Cash Past Year | 1,764,000,000 |
| Total Cash Prior Year | 3,078,000,000 |
| Net Cash Position Most Recent Quarter | -7,021,000,000 |
| Net Cash Position Past Year | -8,610,000,000 |
| Long Term Debt Past Year | 10,374,000,000 |
| Long Term Debt Prior Year | 11,130,000,000 |
| Total Debt Most Recent Quarter | 8,747,000,000 |
| Equity to Debt Ratio Past Year | 0.40 |
| Equity to Debt Ratio Most Recent Quarter | 0.45 |
| Total Stockholder Equity Past Year | 6,964,000,000 |
| Total Stockholder Equity Prior Year | 8,402,000,000 |
| Total Stockholder Equity Most Recent Quarter | 7,241,000,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | 230,000,000 |
| Free Cash Flow Per Share Twelve Trailing Months | 0.45 |
| Free Cash Flow Past Year | 559,000,000 |
| Free Cash Flow Prior Year | 1,290,000,000 |
Options |
|
| Put/Call Ratio | 16.47 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 0.43 |
| MACD Signal | 0.22 |
| 20-Day Bollinger Lower Band | 0.00 |
| 20-Day Bollinger Middle Band | 0.00 |
| 20-Day Bollinger Upper Band | 0.00 |
| Beta | 0.59 |
| RSI | 0.00 |
| 50-Day SMA | 26.21 |
| 150-Day SMA | 33.09 |
| 200-Day SMA | 38.56 |
System |
|
| Modified | 1/12/2026 6:16:47 PM EST |